Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01774741
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
G14 | 2-phenyl-1H-imidazole-4-carboxylic acid | A,B | 3GRJ | 0.71 | |
FOL | FOLIC ACID | A | 1PJ6 | 0.71 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.71 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.71 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.71 | |
FOL | FOLIC ACID | A | 4CD2 | 0.71 | |
FOL | FOLIC ACID | A | 1RX7 | 0.71 | |
FOL | FOLIC ACID | A | 1RX2 | 0.71 | |
FOL | FOLIC ACID | A | 1RX8 | 0.71 | |
FOL | FOLIC ACID | A | 1RA2 | 0.71 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.71 | |
FOL | FOLIC ACID | A | 7DFR | 0.71 | |
FOL | FOLIC ACID | A | 1VIF | 0.71 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.71 | |
FOL | FOLIC ACID | A | 1CD2 | 0.71 | |
FOL | FOLIC ACID | A | 2CD2 | 0.71 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.71 | |
FOL | FOLIC ACID | A | 1DRF | 0.71 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.71 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.71 | |
FOL | FOLIC ACID | A | 1RA8 | 0.71 | |
FR5 | 1-((1R)-1-(HYDROXYMETHYL)-3-(6- ((3-(1-METHYL-1H-BENZIMIDAZOL-2- YL)PROPANOYL)AMINO)-1H-INDOL-1- YL)PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDZ | 0.75 | |
TEL | TELITHROMYCIN | 0,1,2,3,9,A, B,C,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 1YIJ | 0.71 | |
TEL | TELITHROMYCIN | 0 | 1P9X | 0.71 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.71 | |
I19 | N-(4-{[(3S)-3-(dimethylamino)pyrrolidin- 1-yl]carbonyl}phenyl)-5-fluoro- 4-[2-methyl-1-(1-methylethyl)-1H- imidazol-5-yl]pyrimidin-2-amine | A | 2W17 | 0.75 | |
FR4 | 1-((1R)-1-(HYDROXYMETHYL)-3-{6- [(3-PHENYLPROPANOYL)AMINO]-1H-INDOL- 1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1UML | 0.74 | |
FR9 | 1-[(1R)-3-(6-{[(BENZYLAMINO)CARBONYL]AMINO}- 1H-INDOL-1-YL)-1-(HYDROXYMETHYL)PROPYL]- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1O5R | 0.72 | |
IM9 | 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)- 1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin- 1-yl}-2-oxoethanol | A | 2VV9 | 0.7 | |
DG1 | (4S)-ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 2PR2 | 0.72 | |
FXG | N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide | A | 3DAJ | 0.71 | |
1DG | (4R)-ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 2CIG | 0.72 | |
P1H | A,B | 2NTJ | 0.72 | ||
P1H | A,B | 2NTV | 0.72 | ||
HP2 | HYDROXYPYRROLE-IMIDAZOLE-PYRROLE POLYAMIDE | A,B | 1CVX | 0.72 | |
NIL | Nilotinib | A,B,C,D | 3CS9 | 0.7 | |
NIL | Nilotinib | A | 3GP0 | 0.7 | |
IFC | N-[2-methyl-5-({[3-(4-methyl-1H- imidazol-1-yl)-5-(trifluoromethyl)phenyl]carbonyl}amino)phenyl]isoxazole- 5-carboxamide | A | 3DZQ | 0.73 | |
RU6 | A | 2O45 | 0.71 | ||
TFG | 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL- 5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE- 1,1-DIOL | A,B | 2VQQ | 0.73 | |
TFG | 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL- 5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE- 1,1-DIOL | A,B | 2VQO | 0.73 | |
TFG | 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL- 5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE- 1,1-DIOL | A | 2VQJ | 0.73 | |
EAD | A | 2H9I | 0.72 | ||
HP1 | IMIDAZOLE-PYRROLE-HYDROXYPYRROLE POLYAMIDE | A,B | 407D | 0.71 | |
BMI | 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL- 1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN- 2-YLMETHYL)AMINO]PYRIDIN-2(1H)- ONE | A | 2OJ9 | 0.73 | |
PMY | AGLYCON OF PEPLOMYCIN | A | 1AO4 | 0.71 | |
PMY | AGLYCON OF PEPLOMYCIN | A | 1AO2 | 0.71 | |
NGD | A,B | 2O3U | 0.73 | ||
LGF | 1-[(3AR)-5-{[3-(2,4-DIFLUOROPHENYL)- 5,6-DIHYDROIMIDAZO[1,5-A]PYRAZIN- 7(8H)-YL]CARBONYL}-6-METHOXY-3AH- PYRROLO[2,3-B]PYRIDIN-3-YL]-2-[(3R)- 3-HYDROXYPYRROLIDIN-1-YL]-2-OXOETHANONE | A | 2QD9 | 0.81 | |
228 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]- 1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN- 4-YL]-D-PROLINAMIDE | A | 2ORO | 0.7 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1X38 | 0.71 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1LQ2 | 0.71 | |
NAQ | NICOTINAMIDE ADENINE DINUCLEOTIDE 3- PENTANONE ADDUCT | A,B | 1B16 | 0.71 | |
ZID | ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 2IE0 | 0.7 | |
ZID | ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 2IEB | 0.7 | |
ZID | ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 2NV6 | 0.7 | |
ZID | ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 1ZID | 0.7 | |
ZID | ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 2IDZ | 0.7 | |
ZID | ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A,B | 2NQ8 | 0.7 | |
985 | (2E)-3-{3-[6-(4-methyl-1,4-diazepan- 1-yl)pyrazin-2-yl]phenyl}prop-2- enoic acid | A | 3F2A | 0.71 | |
GPB | N-[4-[2-(2-AMINO-4-METHYL-7H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYL]GLUTAMIC ACID | A | 1E26 | 0.7 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.72 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.72 | |
MTX | METHOTREXATE | A | 1U70 | 0.72 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.72 | |
MTX | METHOTREXATE | A | 2QK8 | 0.72 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.72 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.72 | |
MTX | METHOTREXATE | A | 3DAU | 0.72 | |
MTX | METHOTREXATE | A | 1U72 | 0.72 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.72 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.72 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.72 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.72 | |
MTX | METHOTREXATE | A | 1RX3 | 0.72 | |
MTX | METHOTREXATE | A | 3DFR | 0.72 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.72 | |
MTX | METHOTREXATE | A | 3DAT | 0.72 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.72 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.72 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.72 | |
MTX | METHOTREXATE | A | 3EIG | 0.72 | |
MTX | METHOTREXATE | A | 3CD2 | 0.72 | |
MTX | METHOTREXATE | A | 1AO8 | 0.72 | |
MTX | METHOTREXATE | A | 1DF7 | 0.72 | |
MTX | METHOTREXATE | A | 1DLS | 0.72 | |
MTX | METHOTREXATE | A | 1RG7 | 0.72 | |
MTX | METHOTREXATE | A | 1RH3 | 0.72 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.72 | |
MTX | METHOTREXATE | A | 1RA3 | 0.72 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.72 | |
MTX | METHOTREXATE | A | 1DRE | 0.72 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.72 | |
MTX | METHOTREXATE | A | 3CL9 | 0.72 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.72 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.72 | |
FR8 | 1-((1R)-1-(HYDROXYMETHYL)-3-{6- [(5-PHENYLPENTANOYL)AMINO]-1H-INDOL- 1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1QXL | 0.73 | |
AXD | 2-[4-({2-[(2S,5R)-2-(AMINOMETHYL)- 5-ETHYNYLPYRROLIDIN-1-YL]-2-OXOETHYL}AMINO)- 4-METHYLPIPERIDIN-1-YL]ISONICOTINIC ACID | B | 2I03 | 0.72 | |
R86 | 2-{(2R)-4-[2-(1H-IMIDAZOL-1-YL)- 6-METHYLPYRIMIDIN-4-YL]-1-ISOBUTYRYLPIPERAZIN- 2-YL}-N-[2-(4-METHOXYPHENYL)ETHYL]ACETAMIDE | A | 2ORP | 0.71 | |
L1C | (2R,4S)-N^1^-(4-chlorophenyl)-4- (2,4-difluorophenyl)-4-hydroxy- N^2^-(2-oxo-2H-1,3'-bipyridin-6'- yl)pyrrolidine-1,2-dicarboxamide | A | 2W3I | 0.71 | |
RC8 | (2R)-2-({9-(1-methylethyl)-6-[(4- pyridin-2-ylbenzyl)amino]-9H-purin- 2-yl}amino)butan-1-ol | A,C | 3DDP | 0.7 | |
MT1 | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM- 6-YL)METHYL](METHYL)AMINO}BENZOYL)- L-GLUTAMIC ACID | A,B | 2INQ | 0.7 | |
PL1 | COBALT (III)-DEGLYCOPEPLEOMYCIN | B | 1AO1 | 0.71 | |
C24 | 3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER | B,C | 1KTS | 0.71 | |
NAE | NICOTINAMIDE ADENINE DINUCLEOTIDE ACETONE ADDUCT | A,B | 1B15 | 0.71 |